Malaysia Gaming Sector's Recovery May Remain Intact -- Market Talk

Dow Jones

01-27

0208 GMT - The recovery trajectory for Malaysian casino operators is expected to remain robust, driven by rebounding travel demand and visa-free travel pacts between China, Malaysia and Singapore, Hong Leong IB analyst Chee Kok Siang says in a note. He highlights key developments to watch, including Resorts World New York City's bid for a New York casino license, with results expected in late 2025, and Genting Malaysia's potential entry into Thailand's Entertainment Complex. Hong Leong maintains an overweight rating on the gaming sector and pegs Genting as its preferred pick given its strong position to benefit from the recovery of its units Genting Singapore and Genting Malaysia, and potential gains if its associate TauRx Pharmaceuticals' hydromethylthionine mesylate drug secures an FDA approval. (yingxian.wong@wsj.com)

(END) Dow Jones Newswires

January 26, 2025 21:08 ET (02:08 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2506315733"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2506315733\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2506315733?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-27 10:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2506315733","market":"fut","top_or_hot":-1,"title":"Malaysia Gaming Sector's Recovery May Remain Intact -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0208 GMT - The recovery trajectory for Malaysian casino operators is expected to remain robust, driven by rebounding travel demand and visa-free travel pacts between China, Malaysia and Singapore, Hong Leong IB analyst Chee Kok Siang says in a note. He highlights key developments to watch, including Resorts World New York City's bid for a New York casino license, with results expected in late 2025, and Genting Malaysia's potential entry into Thailand's Entertainment Complex. Hong Leong maintains an overweight rating on the gaming sector and pegs Genting as its preferred pick given its strong position to benefit from the recovery of its units Genting Singapore and Genting Malaysia, and potential gains if its associate TauRx Pharmaceuticals' hydromethylthionine mesylate drug secures an FDA approval. (yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 26, 2025 21:08 ET (02:08 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Malaysia Gaming Sector's Recovery May Remain Intact -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMalaysia Gaming Sector's Recovery May Remain Intact -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-01-27 10:08</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0208 GMT - The recovery trajectory for Malaysian casino operators is expected to remain robust, driven by rebounding travel demand and visa-free travel pacts between China, Malaysia and Singapore, Hong Leong IB analyst Chee Kok Siang says in a note. He highlights key developments to watch, including Resorts World New York City's bid for a New York casino license, with results expected in late 2025, and Genting Malaysia's potential entry into Thailand's Entertainment Complex. Hong Leong maintains an overweight rating on the gaming sector and pegs Genting as its preferred pick given its strong position to benefit from the recovery of its units Genting Singapore and Genting Malaysia, and potential gains if its associate TauRx Pharmaceuticals' hydromethylthionine mesylate drug secures an FDA approval. (yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 26, 2025 21:08 ET (02:08 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999016042.SGD","symbol_name":"Schroder Singapore Trust A Acc SGD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2506315733","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2506315733","pubTimestamp":1737943680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Copyright (c) 2025 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999016042.SGD":"Schroder Singapore Trust A Acc SGD","SG9999014484.SGD":"Nikko AM ASEAN Equity Fund A SGD","SG9999005177.SGD":"Legg Mason Martin Currie - Southeast Asia Trust A Acc SGD","SG9999000343.SGD":"Schroder Singapore Trust A Dis SGD","SGXZ27511609.SGD":"NIKKO AM SINGAPORE DIVIDEND EQUITY \"SGD\" (SGD) ACC","G13.SI":"云顶新加坡","BK6066":"赌场与赌博","SG9999014492.USD":"NIKKO AM ASEAN EQUITY \"A\" (USD) ACC","SG9999003826.SGD":"日兴资管新加坡股息基金 SGD","BK6505":"周期性消费品与消费者服务","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD"},"translate_title":"马来西亚博彩业的复苏可能保持不变——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"G13.SI":0.9},"content_text":"0208 GMT - The recovery trajectory for Malaysian casino operators is expected to remain robust, driven by rebounding travel demand and visa-free travel pacts between China, Malaysia and Singapore, Hong Leong IB analyst Chee Kok Siang says in a note. He highlights key developments to watch, including Resorts World New York City's bid for a New York casino license, with results expected in late 2025, and Genting Malaysia's potential entry into Thailand's Entertainment Complex. Hong Leong maintains an overweight rating on the gaming sector and pegs Genting as its preferred pick given its strong position to benefit from the recovery of its units Genting Singapore and Genting Malaysia, and potential gains if its associate TauRx Pharmaceuticals' hydromethylthionine mesylate drug secures an FDA approval. (yingxian.wong@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 26, 2025 21:08 ET (02:08 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}